$101.60
-0.02-0.02%
Last update: Nov 11, 4:00 PM
Lantheus Holdings Inc (LNTH) Stock Price, Quote, News & History
LNTHNASDAQ
Lantheus receives FDA approval for PET imaging agent used to evaluate adults for Alzheimer's disease by identifying tau pathology.
You can purchase shares of Lantheus Holdings (NASDAQ:LNTH) through any online brokerage.
Other companies in Lantheus Holdings’s space includes: Medline Inc (NASDAQ:MDLN), Alcon Inc (NYSE:ALC), Solventum Corp (NYSE:SOLV), Align Technology Inc (NASDAQ:ALGN) and The Cooper Companies Inc (NASDAQ:COO).
Lantheus Holdings has a consensus price target of $110.00.
The stock price for Lantheus Holdings (NASDAQ: LNTH) is $101.6 last updated November 11, 2026 at 4:00 PM EST.
There are no upcoming dividends for Lantheus Holdings.
Lantheus Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Lantheus Holdings.
Lantheus Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision...
